Cargando…

Renal cell carcinoma: links and risks

This review provides an overview of the incidence of renal cell carcinoma (RCC) and a summary of the most commonly associated risk factors. A literature review was performed with a focus on recent studies with a high level of evidence (large prospective cohort studies and meta-analyses). The inciden...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kabaria, Reena, Klaassen, Zachary, Terris, Martha K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4790506/ https://www.ncbi.nlm.nih.gov/pubmed/27022296 http://dx.doi.org/10.2147/IJNRD.S75916

Ejemplares similares

Body mass index and comorbidity are associated with postoperative renal function after nephrectomy
por: Reinstatler, Lael, et al.
Publicado: (2015)

Beyond biology: the impact of marital status on survival of patients with adrenocortical carcinoma
por: Klaassen, Zachary, et al.
Publicado: (2015)

Molecular targeting of renal cell carcinoma by an oral combination
por: Jordan, Andre R., et al.
Publicado: (2020)

Retrograde Robotic Radical Prostatectomy: Description of a New Technique and Early Perioperative Outcomes
por: Vricella, Gino J., et al.
Publicado: (2014)

A Single Surgeon's Experience with Open, Laparoscopic, and Robotic Partial Nephrectomy
por: Klaassen, Zachary, et al.
Publicado: (2014)

Collision metastasis: Renal cell carcinoma and prostatic adenocarcinoma to a retroperitoneal lymph node
por: Morton, Madison, et al.
Publicado: (2021)

High competing risks minimize real-world utility of adjuvant targeted therapy in renal cell carcinoma: a population-based analysis
por: Chandrasekar, Thenappan, et al.
Publicado: (2018)

Impact of Comorbidity, Race, and Marital Status in Men Referred for Prostate Biopsy with PSA >20 ng/mL: A Pilot Study in High-Risk Patients
por: Klaassen, Zachary, et al.
Publicado: (2014)

A modeling study to estimate prostate cancer‐specific mortality on active surveillance for men with favorable intermediate‐risk prostate cancer: Results from the SEARCH cohort
por: Kuhlmann, Paige K., et al.
Publicado: (2023)

Tumor Enucleation for Renal Cell Carcinoma
por: Smith, Zachary L., et al.
Publicado: (2015)

The Association of Fatty Acid Levels and Gleason Grade among Men Undergoing Radical Prostatectomy
por: Zhao, Zhiguo, et al.
Publicado: (2016)

Thalassemia and hepatocellular carcinoma: links and risks
por: Marsella, Maria, et al.
Publicado: (2019)

Characterization and outcomes of local treatment for primary bladder lymphoma: A population-based cohort analysis
por: Sellman, David P., et al.
Publicado: (2018)

Risk Stratification and Treatment Algorithm of Metastatic Renal Cell Carcinoma
por: Grimm, Marc-Oliver, et al.
Publicado: (2021)

Neuroendocrine Carcinomas of the Digestive Tract: What Is New?
por: Pellat, Anna, et al.
Publicado: (2021)

Red Blood Cell Distribution Width Is Associated with All-cause Mortality but Not Adverse Cancer-specific Outcomes in Men with Clinically Localized Prostate Cancer Treated with Radical Prostatectomy: Findings Based on a Multicenter Shared Equal Access Regional Cancer Hospital Registry
por: Orabi, Hazem, et al.
Publicado: (2022)

Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma
por: Wang, Jiaojiao, et al.
Publicado: (2022)

Renal cell carcinoma
por: Jonasch, Eric, et al.
Publicado: (2014)

Epidemiology of Renal Cell Carcinoma
por: Padala, Sandeep Anand, et al.
Publicado: (2020)

Pneumatosis cystoides intestinalis linked to sunitinib treatment for renal cell carcinoma
por: Shikuma, Hiroyuki, et al.
Publicado: (2019)

Uncovering a link between COVID-19 and renal cell carcinoma
por: Gold, Samuel A., et al.
Publicado: (2023)

Clear Cell Renal Cell Carcinoma is linked to Epithelial‐to‐Mesenchymal Transition and to Fibrosis
por: Landolt, Lea, et al.
Publicado: (2017)

Circulating biomarkers in renal cell carcinoma: the link between microRNAs and extracellular vesicles, where are we now?
por: Teixeira, Ana L, et al.
Publicado: (2014)

Renal Preservation Therapy for Renal Cell Carcinoma
por: Chiu, Yichun, et al.
Publicado: (2012)

An Update on the Treatment of Papillary Renal Cell Carcinoma
por: Chawla, Neal S., et al.
Publicado: (2023)

Risk of Chronic Kidney Disease After Nephrectomy for Renal Cell Carcinoma
por: Choi, Seung-Kwon, et al.
Publicado: (2014)

Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy
por: Kelkar, Sonia, et al.
Publicado: (2021)

Diabetes and Risk of Renal Cell Carcinoma
por: Habib, Samy L, et al.
Publicado: (2011)

Wnt Signaling in Renal Cell Carcinoma
por: Xu, Qi, et al.
Publicado: (2016)

Renal cell carcinoma and the use of sorafenib
por: Larkin, James MG, et al.
Publicado: (2006)

Biology of Metastatic Renal Cell Carcinoma
por: Milella, Michele, et al.
Publicado: (2011)

Metabolic syndrome and renal cell carcinoma
por: Zhang, Gui-Ming, et al.
Publicado: (2014)

Hereditary leiomyomatosis and renal cell carcinoma
por: Schmidt, Laura S, et al.
Publicado: (2014)

Axitinib in Metastatic Renal Cell Carcinoma
por: Mittal, Kriti, et al.
Publicado: (2012)

Tivozanib in the treatment of renal cell carcinoma
por: Hepgur, Mehmet, et al.
Publicado: (2013)

Spontaneous regression of renal cell carcinoma
por: Janiszewska, Anna Daria, et al.
Publicado: (2013)

Epidemiology and Prevention of Renal Cell Carcinoma
por: Makino, Tomoyuki, et al.
Publicado: (2022)

Inflammatory Networks in Renal Cell Carcinoma
por: Kruk, Linus, et al.
Publicado: (2023)

Immunotherapy for Renal Cell Carcinoma
por: Itsumi, Momoe, et al.
Publicado: (2010)

Renal Lipid Metabolism Abnormalities in Obesity and Clear Cell Renal Cell Carcinoma
por: Bobulescu, Ion Alexandru, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_emauan106o865gou992dkeugjb